Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β

The Lymphotoxin Network: Orchestrating a Type I interferon response to optimize adaptive immunity

(2014) Jennifer L. Gommerman et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Activin A as a Mediator of NK-Dendritic Cell Functional Interactions

(2014) P. Seeger et al.   JOURNAL OF IMMUNOLOGY

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients

(2014) Katarina M. Mirjačić Martinović et al.   MELANOMA RESEARCH

Booster Vaccinations against Cancer Are Critical in Prophylactic but Detrimental in Therapeutic Settings

(2013) A. Ricupito et al.   CANCER RESEARCH

IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment

(2013) J. L. Wong et al.   CANCER RESEARCH

IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity

(2013) Beatriz M. Carreno et al.   JOURNAL OF CLINICAL INVESTIGATION

IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells

(2013) Georg Gasteiger et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Current Status and Future Perspectives of Dendritic Cell-Based Cancer Immunotherapy

(2013) D. H. Yi et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Regulation of TH2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells

(2012) Beatriz León et al.   NATURE IMMUNOLOGY

Inflammation restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation

(2011) C. H. M. J. Van Elssen et al.   BLOOD

Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria

(2011) Marzia Palma et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Targeted Therapeutic Remodeling of the Tumor Microenvironment Improves an HER-2 DNA Vaccine and Prevents Recurrence in a Murine Breast Cancer Model

(2011) D. Liao et al.   CANCER RESEARCH

Enhanced Cancer Immunotherapy Using STAT3-Depleted Dendritic Cells with High Th1-Inducing Ability and Resistance to Cancer Cell-Derived Inhibitory Factors

(2011) T. Iwata-Kajihara et al.   JOURNAL OF IMMUNOLOGY

Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients

(2011) C. Alfaro et al.   JOURNAL OF IMMUNOLOGY

Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells

(2011) Jeffrey L. Wong et al.   JOURNAL OF IMMUNOTHERAPY

Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial

(2011) Soyoung Baek et al.   Journal of Translational Medicine

Loss of NK Stimulatory Capacity by Plasmacytoid and Monocyte-Derived DC but Not Myeloid DC in HIV-1 Infected Patients

(2011) Adel Benlahrech et al.   PLoS One

Blood Dendritic Cells Suppress NK Cell Function and Increase the Risk of Leukemia Relapse after Hematopoietic Cell Transplantation

(2010) Antonio Perez-Martinez et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum Coronarium L.

(2010) Sachi Tanaka et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative Regulator of DC Function

(2010) Jessica A. Melillo et al.   JOURNAL OF IMMUNOLOGY

Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies

(2010) M Le Garff-Tavernier et al.   LEUKEMIA

Antigen-bearing dendritic cells regulate the diverse pattern of memory CD8 T-cell development in different tissues

(2010) C.-H. Shen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Activin-A attenuates several human natural killer cell functions

(2009) N. C. Robson et al.   BLOOD

Generation of a Dendritic Cell-based Vaccine in Chronic Lymphocytic Leukaemia Using CliniMACS Platform for Large-scale Production

(2009) L. Adamson et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY